ExpreS2ion Biotech Holding AB rights issue of SEK 131m.

Arctic Securities acted as financial advisor to the Danish Nasdaq First North listed company ExpreS2ion Biotech Holding AB (publ) in relation to the rights issue of SEK 131m. The rights issue was received with great interest which resulted in a subscription of over 140 percent (SEK 186m). We are grateful for the vote of confidence and congratulate on the successful transaction!

Latest news

  1. Arctic Securities -

    IMPORTANT NOTICE — ARCTICSAS

    Arctic Securities is not affiliated with "Arctic SAS" or www.arcticsas.com.

    We have been made aware that unknown parties are using the Arctic Securities name, logo and trademark in connection with investment offers directed at private individuals abroad.